how-to-read-research hub
Novo Nordisk's CEO believes investors are underestimating the demand for differentiation among obesity drugs, and that new treatment options like pills will prevent the market from becoming a winner-take-all battle with rival Eli Lilly.
The U.S. FDA has approved Bristol Myers Squibb’s oral drug iberdomide, marketed as Zenbexus, for use with daratumumab and dexamethasone in patients with relapsed or refractory multiple myeloma, marking the first approval of a novel drug class for the disease and the inaugural use of a more sensitive remission endpoint in the United States.
The American Academy of Pediatrics (AAP) addresses federal leaders' misleading claims about vaccines, reaffirming the safety and importance of childhood immunizations. Pediatricians emphasize evidence-based recommendations, debunk myths, and reassure parents amid growing misinformation.